CD81 knockout promotes chemosensitivity and disrupts in vivo homing and engraftment in acute lymphoblastic leukemia

Continuous signaling of CD79b and CD19 is required for the fitness of Burkitt lymphoma B cells

(2018) Xiaocui He et al.   EMBO JOURNAL

Role of CD81 and CD58 in minimal residual disease detection in pediatric B lymphoblastic leukemia

(2018) E. Tsitsikov et al.   International Journal of Laboratory Hematology

Easy discrimination of hematogones from lymphoblasts in B-cell progenitor acute lymphoblastic leukemia patients using CD81/CD58 expression ratio

(2018) Carole Nagant et al.   International Journal of Laboratory Hematology

BTK: a two-faced effector in cancer and tumour suppression

(2018) Miran Rada et al.   Cell Death & Disease

Epigenetic drug combination overcomes osteoblast-induced chemoprotection in pediatric acute lymphoid leukemia

(2017) Anthony Quagliano et al.   LEUKEMIA RESEARCH

Eviction from the sanctuary: Development of targeted therapy against cell adhesion molecules in acute lymphoblastic leukemia

(2017) Sonali P. Barwe et al.   SEMINARS IN ONCOLOGY

Standardized flow cytometry for highly sensitive MRD measurements in B-cell acute lymphoblastic leukemia

(2016) Prisca Theunissen et al.   BLOOD

BTK Modulates p53 Activity to Enhance Apoptotic and Senescent Responses

(2016) Mohammad Althubiti et al.   CANCER RESEARCH

Tetraspanins: Spanning from solid tumors to hematologic malignancies

(2016) Ying-Gui Yang et al.   EXPERIMENTAL HEMATOLOGY

Tetraspanin CD81 is an adverse prognostic marker in acute myeloid leukemia

(2016) Thomas Boyer et al.   Oncotarget

Generation of Pediatric Leukemia Xenograft Models in NSG-B2m Mice: Comparison with NOD/SCID Mice

(2016) Anilkumar Gopalakrishnapillai et al.   Frontiers in Oncology

Treatment with Ibrutinib Inhibits BTK- and VLA-4-Dependent Adhesion of Chronic Lymphocytic Leukemia Cells In Vivo

(2015) S. E. M. Herman et al.   CLINICAL CANCER RESEARCH

Wiskott-Aldrich Syndrome Interacting Protein Deficiency Uncovers the Role of the Co-receptor CD19 as a Generic Hub for PI3 Kinase Signaling in B Cells

(2015) Selina Jessica Keppler et al.   IMMUNITY

Treatment of Pediatric Acute Lymphoblastic Leukemia

(2015) Stacy L. Cooper et al.   PEDIATRIC CLINICS OF NORTH AMERICA

Disruption of Annexin II /p11 Interaction Suppresses Leukemia Cell Binding, Homing and Engraftment, and Sensitizes the Leukemia Cells to Chemotherapy

(2015) Anilkumar Gopalakrishnapillai et al.   PLoS One

Stromal cell-mediated mitochondrial redox adaptation regulates drug resistance in childhood acute lymphoblastic leukemia

(2015) Jizhong Liu et al.   Oncotarget

Tetraspanins as therapeutic targets in hematological malignancy: a concise review

(2015) Kyle A. Beckwith et al.   Frontiers in Physiology

Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF- B mediates chemoresistance

(2014) R. Jacamo et al.   BLOOD

Tetraspanins at a glance

(2014) S. Charrin et al.   JOURNAL OF CELL SCIENCE

The membrane scaffold CD82 regulates cell adhesion by altering α4 integrin stability and molecular density

(2014) Christina M. Termini et al.   MOLECULAR BIOLOGY OF THE CELL

Easy quantitative assessment of genome editing by sequence trace decomposition

(2014) Eva K. Brinkman et al.   NUCLEIC ACIDS RESEARCH

Role of Integrin Alpha4 in Drug Resistance of Leukemia

(2014) Stephanie Shishido et al.   Frontiers in Oncology

Adhesion to osteopontin in the bone marrow niche regulates lymphoblastic leukemia cell dormancy

(2013) B. Boyerinas et al.   BLOOD

Integrin alpha4 blockade sensitizes drug resistant pre-B acute lymphoblastic leukemia to chemotherapy

(2013) Y.-T. Hsieh et al.   BLOOD

Acute lymphoblastic leukaemia

(2013) Hiroto Inaba et al.   LANCET

Genome engineering using the CRISPR-Cas9 system

(2013) F Ann Ran et al.   Nature Protocols

Tetraspanins CD81 and CD82 Facilitate α4β1-Mediated Adhesion of Human Erythroblasts to Vascular Cell Adhesion Molecule-1

(2013) Frances A. Spring et al.   PLoS One

How I treat relapsed childhood acute lymphoblastic leukemia

(2012) F. Locatelli et al.   BLOOD

The clinically active BTK inhibitor PCI-32765 targets B-cell receptor- and chemokine-controlled adhesion and migration in chronic lymphocytic leukemia

(2012) M. F. M. de Rooij et al.   BLOOD

The bone marrow microenvironment and leukemia: biology and therapeutic targeting

(2011) Edward Allan R Sison et al.   Expert Review of Hematology

CD81 gene defect in humans disrupts CD19 complex formation and leads to antibody deficiency

(2010) Menno C. van Zelm et al.   JOURNAL OF CLINICAL INVESTIGATION

Comparison of the multi-drug resistant human hepatocellular carcinoma cell line Bel-7402/ADM model established by three methods

(2010) Xingguo Zhong et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

A New α5β1 Integrin-Dependent Survival Pathway Through GSK3β Activation in Leukemic Cells

(2010) Fabienne De Toni-Costes et al.   PLoS One

Aberrant Underexpression of CD81 in Precursor B-Cell Acute Lymphoblastic Leukemia

(2009) Tariq Muzzafar et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Outcome of Patients Treated for Relapsed or Refractory Acute Lymphoblastic Leukemia: A Therapeutic Advances in Childhood Leukemia Consortium Study

(2009) Richard H. Ko et al.   JOURNAL OF CLINICAL ONCOLOGY

Contribution of bone microenvironment to leukemogenesis and leukemia progression

(2009) F Ayala et al.   LEUKEMIA

Tetraspanin-enriched microdomains: a functional unit in cell plasma membranes

(2009) María Yáñez-Mó et al.   TRENDS IN CELL BIOLOGY

Endothelial adhesion receptors are recruited to adherent leukocytes by inclusion in preformed tetraspanin nanoplatforms

(2008) Olga Barreiro et al.   JOURNAL OF CELL BIOLOGY